Physician profile
Craig Brown
NPI 1841808409
$2,504.90
in general payments reported to CMS, 2019-2025
19 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.24 · 2021: $987 · 2022: $588 · 2023: $208 · 2024: $324 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861 · Education: $57.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.48 |
| Education | $57.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $453.78 | 2021-2025 | |
| Alcon Vision LLC | $394.74 | 2022-2025 | Total30, Precision7, Precision 1 |
| Eyevance Pharmaceuticals LLC | $306.72 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $256.58 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $200.79 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $113.09 | 2021-2023 | |
| Johnson & Johnson Vision Care, INC. | $107.82 | 2022-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $99.36 | 2022-2025 | Infuse, Biotrue One Day |
| Glaukos Corporation | $96.01 | 2022-2025 | Photrexa Viscous and Photrexa |
| Coopervision INC. | $84.79 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Sight Sciences, INC. | $79.50 | 2022 | |
| Allergan, INC. | $64.27 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2024 | |
| Mallinckrodt Hospital Products INC. | $50.70 | 2021 | |
| Abbvie INC. | $45.45 | 2022-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $32.31 | 2021 | |
| Oyster Point Pharma, INC. | $26.43 | 2022 | |
| Biotissue Holdings INC. | $19.31 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.